echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurol: Changes in Stroke Diagnosis and Treatment in Rural and Urban America - 2008-2017

    JAMA Neurol: Changes in Stroke Diagnosis and Treatment in Rural and Urban America - 2008-2017

    • Last Update: 2020-05-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Over the past decade, investments in stroke treatment and care have significantly improved the opportunities and quality of care for stroke patients in rural areasRecently, researchers compared differences in medical treatment, care and patient outcomes in rural and urban patients with acute ischemic stroke or transient cerebral ischemic attacksstudy looked at Data for Medicare claims in the United States for 2008-2017, including all rural and urban areas, including a total of 4.01 million patients with transient ischemic attacks or acute strokes who lived in urban or rural areas and were hospitalized for transient ischemic attacks or acute strokeThe main endpoints of the study were discharge from a certified stroke center, neurologic consultation sat, treated with atepase, days of hospitalization and 90 days of mortalitythe final sample included 3.47 million patients, of which 2.01 million (58.0%) were women, with an average age of 78.6 yearsIn 2008, 24,681 patients (25.2 per cent) and 161,217 (60.6 per cent) were treated in accredited stroke centres in both rural and urban areas (the gap was -35.4 per cent)By 2017, the gap was -26.6 per cent, a narrowing of 8.7 per centDuring admission, the urban-rural gap assessed by neurologists was also narrowing (6.3 per cent), while the gap between urban and rural areas in receiving atepase treatment (0.5 per cent), admission (0.5 days) and 90-day mortality (0.3 per cent) widened or similarstudies suggest that over the past decade, more and more rural patients with acute ischemic stroke and transient cerebral ischemic attacks have received certified professional treatment, but gaps in access to soto syllables (such as atepase) and treatment outcomes remain
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.